JD Health International Inc.
6618
Pozycja w akcjach
#1399
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Cena akcji
$4.98
Kapitalizacja rynkowa
$15.89B
Zmiana (1 dzień)
-2.21%
Zmiana (1 rok)
-39.77%
Kraj
CN
Handel JD Health International Inc. (6618)
Kategoria
Healthcare
Zyski dla JD Health International Inc. (6618)
Zyski w Jun 2026 TTM: $1.07B
Według najnowszych raportów finansowych JD Health International Inc., obecny zysk firmy wynosi $1.07B. W roku 2023 firma osiągnęła zysk w wysokości $380.49M, wzrost w porównaniu do zysku z roku 2022, który wynosił $100.87M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy JD Health International Inc. od 2017 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $1.07B | 62.26% |
| 2024 | $657.16M | 72.71% |
| 2023 | $380.49M | 277.20% |
| 2022 | $100.87M | -171.12% |
| 2021 | $-141.84M | -94.57% |
| 2020 | $-2.61B | 2,080.12% |
| 2019 | $-119.87M | -369.26% |
| 2018 | $44.52M | 13.15% |
| 2017 | $39.34M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $9.87B | 825.69% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 262.46% |
US
|
|
| $687.82M | -35.50% |
SA
|
|
| $1.25B | 16.92% |
BR
|
